Genotypic Correlates of a Virologic Response to Stavudine After Zidovudine Monotherapy

This publication has 16 references indexed in Scilit:

• Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine
  Journal of Medical Virology, 1999
• Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy
  AIDS, 1999
• Evidence of Stavudine-Related Phenotypic Resistance Among Zidovudine-Pretreated HIV-1–Infected Subjects Receiving a Therapeutic Regimen of Stavudine Plus Lamivudine
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• Genotypic And Phenotypic Analysis Of Human Immunodeficiency Virus Type 1 Isolates From Patients On Prolonged Stavudine Therapy
  The Journal of Infectious Diseases, 1994
• Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture
  Antimicrobial Agents and Chemotherapy, 1994
• Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance
  Journal of General Virology, 1994
• Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.
  Proceedings of the National Academy of Sciences, 1992
• Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive Subjects
  The Journal of Infectious Diseases, 1992
• Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
  Science, 1991
• Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
  Science, 1989